Literature DB >> 22449262

Cannabinoids, working memory, and schizophrenia.

Patrick D Skosnik1, Mohini Ranganathan, Deepak Cyril D'Souza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22449262     DOI： 10.1016/j.biopsych.2012.02.028

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  3 in total

1.  The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.

Authors:  Else-Marie Løberg; Siri Helle; Merethe Nygård; Jan Øystein Berle; Rune A Kroken; Erik Johnsen
Journal:  Front Psychiatry       Date:  2014-11-18       Impact factor: 4.157

2.  An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use.

Authors:  Else-Marie Løberg; Merethe Nygård; Jan Øystein Berle; Erik Johnsen; Rune A Kroken; Hugo A Jørgensen; Kenneth Hugdahl
Journal:  Front Psychiatry       Date:  2012-10-30       Impact factor: 4.157

3.  Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls.

Authors:  Rodrigo Ferretjans; Renan P de Souza; Bruna Panizzutti; Pâmela Ferrari; Lucas Mantovani; Salvina M de Campos-Carli; Rafael R Santos; Fernanda C Guimarães; Antonio L Teixeira; Clarissa S Gama; João V Salgado
Journal:  Braz J Psychiatry       Date:  2022 Jan-Feb       Impact factor: 2.697
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.